Abbott recalls glucose sensors after seven deaths linked to faulty readings
Feb 4 (Reuters) - Abbott ABT.N has recalled certain glucose monitoring sensors after reports linked the devices to seven deaths and 860 serious injuries, the U.S. health regulator said on Wednesday. (Reporting by Kamal Choudhury in Bengaluru; Editing by Shilpi Majumdar) ((Kamal.Choudhury@thomsonreuters.com;))
Recent news on Abbott Laboratories
See all newsBrief: FDA Approves Abbott HIV Combo Next Assay
Press Digest: Wall Street Journal - June 29
US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports (updated)
US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports
Factbox: Major deals involving US drugmakers and biotechs over the past decade